On 06/13/2025 the number of shorted ATHE shares was still 116,787. I think during the past 2 days it has come down. Big Pharma needs the 202 results and the missing results of the 201 study. Maybe we get them in 2-3 weeks. New estimates of 434 sales potential can come earlier. Stamler seems to sell 434 more and more as a mitochondrion drug to improve energy production (lack of energy is killing the nerves) and not an iron chelator (?) but an iron distributer also inside the cell. Alpha-synuclein elimination needs energy, not antibodies. IMO. Do your own speculations!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $41.54K | 4.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 11136808 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4729475 | 10 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |